abstract |
This disclosure relates to constructs, e. G., Antibody molecules, comprising binding domains specific for CD45, including SEQ ID NOs: 1, 2, 3 and / or SEQ ID NOs: 4, 5 and 6. This disclosure extends to the pharmaceutical compositions comprising the constructs and to the uses of the constructs / compositions in therapy. |